TLR4 and neoplasm: To identify whether TLR4 signaling pathway participates in the anti-tumor and immunomodulatory effects of APS in vivo, C57BL/10 J (TLR4+/+) and TLR4-deficient (TLR4−/−) tumor-bearing mice were applied in this study.